Company Data

Nascent Biotech Inc

Ticker
NBIO
Current Price
$0.0075
Market Cap
$1.3M
Price Target
Refer to Report
52wk Range
$0.0002 - $0.19
Advanced Market Data

Overview

Nascent Biotech Inc is a United States-based clinical stage biopharmaceutical company. It is focused on the development and delivery of human antibodies and cytokine responses to the treatment of cancer. The company’s products include Pritumumab, CLNH5, and MultiPharm. It is actively engaged in the development of Pritumumab which would be used for the treatment of brain cancer and pancreatic cancer. They are also exploring the use of Pritumumab against other viruses.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy